Literature DB >> 26387852

Dietary lipids modulate the expression of miR-107, a miRNA that regulates the circadian system.

Lidia Daimiel-Ruiz1, Mercedes Klett-Mingo1, Valentini Konstantinidou1, Victor Micó1, Juan Francisco Aranda2,3, Belén García1, Javier Martínez-Botas4, Alberto Dávalos1, Carlos Fernández-Hernando2,3, José Maria Ordovás1,5.   

Abstract

SCOPE: The increased prevalence of cardiovascular diseases (CVDs) has been hypothesized to be the result of an increased exposure to a host of atherogenic environmental factors, paramount among them being unhealthy dietary habits. Long-chain n-3 polyunsaturated fatty acids (PUFAs) have been shown to have cardio protective effects, partially due to their ability to regulate gene expression. In this regard, increasing attention has been devoted to the role of miRNAs as regulators of multiple metabolic pathways whose deregulation has been associated with CVD risk. In this work we investigated whether miRNA expression was regulated by docosahexanoic acid, conjugated linoleic acid and cholesterol in Caco-2 cells.
RESULTS: Among the modulated miRNAs, miR-107 was differentially expressed by all treatments and this modulation was independent of its hosting gene, panthothenate kinase 1, possibly through its own promoter, which contains binding sites for metabolically relevant transcription factors. Among the putative target genes of miR-107, we found some genes with key roles in circadian rhythm. Specifically, we demonstrated that binding of miR-107 to the circadian locomotor output cycles kaput gene results in the deregulation of the circadian rhythm of the cells.
CONCLUSION: Since chronodisruption has been linked to metabolic disorders such as type 2 diabetes, atherosclerosis, obesity, and CVD, our findings suggest that miR-107 could represent a new approach for pharmacological treatment of these diseases.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Circadian rhythm; DHA; Dietary lipids; miR-107

Year:  2015        PMID: 26387852     DOI: 10.1002/mnfr.201570094

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  12 in total

Review 1.  Interplay of mitochondrial metabolism and microRNAs.

Authors:  Julian Geiger; Louise T Dalgaard
Journal:  Cell Mol Life Sci       Date:  2016-08-25       Impact factor: 9.261

2.  MicroRNA-370 suppresses the progression and proliferation of human astrocytoma and glioblastoma by negatively regulating β-catenin and causing activation of FOXO3a.

Authors:  Ming Lu; Yong Wang; Shizhen Zhou; Jun Xu; Jing Li; Rongjie Tao; Yufang Zhu
Journal:  Exp Ther Med       Date:  2017-11-13       Impact factor: 2.447

Review 3.  Circadian Regulation of Glutamate Transporters.

Authors:  Donají Chi-Castañeda; Arturo Ortega
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-21       Impact factor: 5.555

4.  Crosstalk between microRNAs, the putative target genes and the lncRNA network in metabolic diseases.

Authors:  Taís Silveira Assmann; Fermín I Milagro; José Alfredo Martínez
Journal:  Mol Med Rep       Date:  2019-08-21       Impact factor: 2.952

Review 5.  Chronodisruption: A Poorly Recognized Feature of CKD.

Authors:  Sol Carriazo; Adrián M Ramos; Ana B Sanz; Maria Dolores Sanchez-Niño; Mehmet Kanbay; Alberto Ortiz
Journal:  Toxins (Basel)       Date:  2020-02-28       Impact factor: 4.546

6.  MicroRNA-107 inhibits proliferation and invasion of laryngeal squamous cell carcinoma cells by targeting CACNA2D1 in vitro.

Authors:  Chaoping Huang; Zhenxiao Wang; Kun Zhang; Yanbo Dong; Aobo Zhang; Cheng Lu; Liangfa Liu
Journal:  Anticancer Drugs       Date:  2020-03       Impact factor: 2.389

7.  Impact of Phenol-Enriched Virgin Olive Oils on the Postprandial Levels of Circulating microRNAs Related to Cardiovascular Disease.

Authors:  Lidia Daimiel; Víctor Micó; Rosa M Valls; Anna Pedret; María José Motilva; Laura Rubió; Montse Fitó; Marta Farrás; María Isabel Covas; Rosa Solá; José M Ordovás
Journal:  Mol Nutr Food Res       Date:  2020-07-01       Impact factor: 5.914

8.  microRNA-155 Is Decreased During Atherosclerosis Regression and Is Increased in Urinary Extracellular Vesicles During Atherosclerosis Progression.

Authors:  Stephen Fitzsimons; Silvia Oggero; Robyn Bruen; Cathal McCarthy; Moritz J Strowitzki; Niall G Mahon; Nicola Ryan; Eoin P Brennan; Mary Barry; Mauro Perretti; Orina Belton
Journal:  Front Immunol       Date:  2020-12-17       Impact factor: 7.561

9.  The Circulating Micro-RNAs (-122, -34a and -99a) as Predictive Biomarkers for Non-Alcoholic Fatty Liver Diseases.

Authors:  Olfat M Hendy; Hatem Rabie; Amr El Fouly; Mohamed Abdel-Samiee; Nashwa Abdelmotelb; Amr Aly Elshormilisy; Mahmoud Allam; Samia Taher Ali; Nessren Mohamed Bahaa El-Deen; Shimaa Abdelsattar; Somia Mokabel Mohamed
Journal:  Diabetes Metab Syndr Obes       Date:  2019-12-19       Impact factor: 3.168

Review 10.  The Promise and Challenge of Therapeutic MicroRNA Silencing in Diabetes and Metabolic Diseases.

Authors:  Praveen Sethupathy
Journal:  Curr Diab Rep       Date:  2016-06       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.